AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment

2

Oct 5 (Reuters) – AstraZeneca said on Monday it had opened a new research and development center in Cambridge, Massachusetts, as part of a more than $1 billion investment in the state to expand its

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)